Lantheus (LNTH) Q1 FY26 earnings call

Lantheus delivered a strong Q1 FY26, driven by solid performance across its core products and significant regulatory milestones for PYLARIFY TRUVU and PNT2003. The company reaffirmed its full-year guidance, balancing early-year strength with upcoming competitive dynamics and a CEO transition. Strategic focus remains on radio diagnostics, advancing its late-stage pipeline, and disciplined capital allocation to accelerate growth in 2027.